New drug shows promise in repairing failing hearts
New drug shows promise in repairing failing hearts A new experimental drug has shown promise in restoring cardiac function after heart failure, according to results of an early human trial. The researchers found that an infusion of the drug cimaglermin was generally tolerated except for transient nausea and headache. “These findings support continued clinical development of the investigational drug cimaglermin, including further safety evaluations and detailing the potential improvement on clinical heart failure outcome measures,” said lead author of the study Daniel Lenihan from Vanderbilt University in Nashville, Tennessee, US.…
Read More